SPARK-TECH: Pioneering the Future of Medical and Biological Research
Established in 2015 and based in Krakow, Poland, SPARK-TECH is committed to revolutionizing the research fields of medicine and biology by providing innovative, autonomous, user-friendly, secure, and affordable laboratory equipment, harnessing the power of artificial intelligence, robotics, and information engineering.
Our collaborative work with individual inventors, research groups, and public universities has led to a diverse portfolio of cutting-edge patents. One of our groundbreaking inventions, the Spark-Tech Biobanking System (STBS), offers an automated, time-efficient, and cost-effective solution for the separation, preservation, and biobanking of human Peripheral Blood Mononuclear Cells (PBMCs). The system consists of two robotic autonomous medical devices: a separation robot and a biobank.
The STBS project has garnered significant recognition, receiving funding from the European Commission’s Instrument SME program in 2016 and 2018, along with the prestigious “Seal of Excellence” certificate in 2019. Additionally, it secured national funding from NCBR in 2019. Currently, SPARK-TECH’s primary focus is the market launch of STBS and its ongoing development, which received further national funding from PARP in 2022.
In 2023, we expanded our offerings by introducing a microbiome diagnostic service based on third-generation sequencing. This service caters to both human and agricultural needs, aiming to reduce antibiotic usage and enhance treatment strategies, paving the way for a healthier future.